Corteva, Inc. CTVA
- Market cap
- $53.0B
- P/E
- 52.0×
Follow CTVA
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | 24.10 | 20.38 | 36.54 | 43.74 | 43.22 | 44.01 | 53.40 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | 32.78 | 40.23 | 49.98 | 68.43 | 65.21 | 64.20 | 77.41 |
High Price
|
|||
| — | — | — | — | 21,000 | 21,000 | 21,000 | 22,500 | 22,000 | 21,500 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Revenue/Emp
|
|||
| 23,221 | 10,684 | 14,287 | 13,846 | 14,217 | 15,655 | 17,455 | 17,226 | 16,908 | 17,401 |
Revenue
|
|||
| 40.11% | 40.81% | 30.37% | 38.07% | 40.16% | 41.11% | 40.21% | 42.41% | 43.64% | 47.29% |
Gross Margin
|
|||
| 2,723 | (498) | (6,806) | (316) | 675 | 2,346 | 1,426 | 1,093 | 1,275 | 1,688 |
EBT
|
|||
| 11.73% | (4.66%) | (47.64%) | (2.28%) | 4.75% | 14.99% | 8.17% | 6.35% | 7.54% | 9.70% |
EBT Margin
|
|||
| 2,070 | 2,953 | (5,027) | (941) | 701 | 1,769 | 1,158 | 747 | 919 | 1,105 |
Net Income
|
|||
| 1,226 | 3,208 | 8,921 | 2,973 | 1,177 | 1,243 | 1,223 | 1,211 | 1,227 | 1,203 |
Depreciation
|
|||
| 31.00 | 14.26 | 19.06 | 18.47 | 18.99 | 21.27 | 24.22 | 24.30 | 24.37 | 25.59 |
Revenue/Sh
|
|||
| 3.34 | 3.94 | (6.71) | (1.28) | 0.91 | 2.39 | 1.59 | 1.04 | 1.31 | 1.60 |
Earnings/Sh
|
|||
| 4.48 | (0.37) | 0.64 | 1.43 | 2.76 | 3.71 | 1.21 | 2.50 | 3.09 | 5.01 |
Cash Flow/Sh
|
|||
| 0.00 | 1.95 | (1.91) | (1.22) | (0.52) | (0.68) | (0.74) | (0.76) | (0.85) | (0.79) |
Capex/Sh
|
|||
| 4.48 | 1.59 | (1.27) | 0.21 | 2.23 | 3.03 | 0.47 | 1.74 | 2.24 | 4.22 |
Free CF/Sh
|
|||
| 0.00 | 0.00 | 100.28 | 32.76 | 33.48 | 34.82 | 35.43 | 35.65 | 34.64 | 35.86 |
Book Value/Sh
|
|||
| 749 | 749 | 749 | 750 | 749 | 736 | 721 | 709 | 694 | 680 |
Shares
|
|||
| 120.83 | 120.83 | 120.83 | 0.00 | 43.02 | 19.87 | 37.30 | 47.15 | 44.16 | 42.42 |
PE Ratio
|
|||
| 0.00 | 0.00 | 0.00 | 1.60 | 2.04 | 2.22 | 2.43 | 2.00 | 2.34 | 2.62 |
PS Ratio
|
|||
| 0.29 | 0.29 | 0.29 | 0.90 | 1.16 | 1.36 | 1.66 | 1.36 | 1.64 | 1.87 |
PB Ratio
|
|||
| 0.00 | 0.00 | 0.00 | 1.48 | 1.85 | 2.00 | 2.32 | 1.98 | 2.31 | 2.51 |
EV/Sales
|
|||
| (9.05) | (9.05) | (9.05) | 131.46 | 15.73 | 14.07 | 119.03 | 27.76 | 25.14 | 15.21 |
EV/FCF
|
|||
| 3,357 | (275) | 483 | 1,070 | 2,064 | 2,727 | 872 | 1,769 | 2,145 | 3,406 |
Op' Cash Flow
|
|||
| (1,019) | 1,465 | (1,432) | (914) | (392) | (498) | (532) | (538) | (592) | (537) |
Capex
|
|||
| 3,357 | 1,190 | (949) | 156 | 1,672 | 2,229 | 340 | 1,231 | 1,553 | 2,869 |
FCF
|
|||
| — | 10,912 | 9,662 | 5,281 | 6,220 | 5,988 | 6,051 | 5,851 | 4,711 | 5,210 |
Working Cap'
|
|||
| — | 13,070 | 7,938 | 122 | 1,105 | 1,117 | 1,307 | 2,489 | 2,703 | 2,580 |
Total Debt
|
|||
| — | 4,310 | 5,663 | (1,647) | (2,690) | (3,428) | (2,008) | (253) | (466) | (1,950) |
Net Debt
|
|||
| — | 0 | 75,153 | 24,555 | 25,063 | 25,623 | 25,541 | 25,279 | 24,030 | 24,386 |
Sh' Equity
|
|||
| 0.00% | 2.63% | (9.32%) | (1.27%) | 1.60% | 4.14% | 2.70% | 1.72% | 2.16% | 2.62% |
ROA
|
|||
| — | (1.87%) | (5.00%) | (0.49%) | 2.01% | 6.69% | 4.00% | 3.31% | 4.00% | 5.20% |
ROIC
|
|||
| 0.00% | 3.91% | (6.77%) | (1.92%) | 2.74% | 6.94% | 4.48% | 2.89% | 3.68% | 4.52% |
ROE
|
|||
Corteva, Inc. peers in Agricultural Inputs
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| NTR Nutrien Ltd. | $35.4B | 14.6× | Compare |
| CF CF Industries Holdings, Inc. | $17.9B | 8.5× | Compare |
| MOS The Mosaic Company | $7.5B | 0.0× | Compare |
| ICL ICL Group Ltd. | $6.7B | 21.4× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| SMG The Scotts Miracle-Gro Company | $3.0B | 40.7× | Compare |
| UAN CVR Partners, LP | $1.3B | 8.1× | Compare |
| FMC FMC Corporation | $1.2B | 0.0× | Compare |
| IPI Intrepid Potash, Inc | $482.3M | 17.0× | Compare |
CTVA metrics, ten years each
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
Corteva, Inc. (CTVA) key facts
- Corteva, Inc. (CTVA) is an Agricultural Inputs company in the Basic Materials sector, listed on the New York Stock Exchange.
- Corteva, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 2.92% from fiscal 2024.
- Net income was $1.1 billion, or $1.60 per share (basic), a net margin of 6.29%.
- As of September 25, 2026, CTVA traded at $78.52, a market capitalization of $53.0 billion.
- At that price the stock trades at 52.0× trailing-twelve-month earnings and 2.9× sales.
- Corteva, Inc. pays an annual dividend of $0.64 per share, a yield of 1.31%, with a payout ratio of 38.2%.
- Return on equity was 4.52% and debt-to-equity 0.19.
Corteva, Inc. (CTVA) Latest News
24 Sep
INDIANAPOLIS, Sept. 24, 2026 /PRNewswire/ — Corteva (NYSE: CTVA) announced that the U.S. Securities and Exchange Commission has declared Vylor's Registration Statement on Form 10 effective. The Form 10 outlines Vylor’s business, strategy, priorities and the planned separation into an independent, publicly traded company, expected to close on Oct. 1, 2026. Following the separation, Corteva shareholders of record as of the close of business on Sept. 24, 2026 will receive one share of Vylor common stock for each Corteva share held. The distribution is anticipated before 9:30 a.m. ET on Oct. 1, 2026. Vylor will be listed on the NYSE under symbol VYLR beginning Oct. 1, 2026. There will be no when-issued trading in Corteva or ex-distribution trading in Corteva stock. Spin-off creates a major corporate restructuring, altering Corteva's business mix and investor base, with potential material implications for value and capitalization.
21 Sep
Vylor, Corteva's planned spin-off on Oct. 1, 2026, and Rainbow Crops, a VIB spin-off, will collaborate to advance gene-edited corn traits using Rainbow Crops' AI-supported Trait Foundry and multiplex editing. The partnership aims to develop hybrids more resilient to heat, drought, and floods, with more efficient inputs and higher yield, validated via high-throughput phenotyping and field trials. Mat Muller will lead Vylor Edge, Vylor's investment platform, which will leverage Rainbow Crops' platform to edit hundreds of genes simultaneously. The collaboration aligns with Europe's June 2026 policy allowing gene-edited plants to be imported and cultivated. Corteva Catalyst-backed Rainbow Crops investment will become part of Vylor Edge after the spin-off. The release contains forward-looking statements and risk disclosures. Spin-off retools Corteva's asset base and shifts biotech exposure via the Rainbow Crops stake into Vylor Edge.
19 Sep
Corteva partners with a Belgian firm to advance crop protection initiatives as a core strategic move. Strategic Belgian partnership targets Corteva's core crop protection segment and could meaningfully shift innovation and competitive positioning.
17 Sep
Chemours settled PFAS claims for US$455 million, establishing a benchmark that may reduce perceived long-term liability exposure for Corteva. Chemours settlement supplies a valuation reference point for Corteva's own PFAS-related risks.
15 Sep
Corteva (CTVA) investors face ongoing fight over Vylor spin-off with key developments to monitor for potential structural changes. Vylor spin-off dispute represents major strategic move likely to alter Corteva trajectory and investor sentiment.
Vylor expands soybean leadership with next-gen tech platforms maintaining North America yield advantage and accelerating Latin America lineup through broad spectrum insect control. Next-gen soybean platforms strengthen Corteva competitive edge and market reach in core regions.
Corteva's Vylor confirms breakthrough wheat technology launch in 2027. Breakthrough wheat technology launch in 2027 will significantly boost Corteva's competitive position in agricultural markets.
Corteva investors should mark September 15 as a key date likely tied to earnings or major company update. September 15 date announcement may affect near-term trading sentiment but does not signal structural change.
14 Sep
Corteva board approves spinoff of seed business as Vylor. Seed business spinoff constitutes major strategic restructuring that will alter Corteva operations and market positioning.
Corteva board approved Vylor distribution. Board approval of Vylor distribution signals corporate restructuring with moderate effects on operations.
10 Sep
Corteva Inc. along with Chemours and DuPont reached an agreement to resolve PFAS-related claims in North Carolina. Agreement resolves PFAS litigation risks for Corteva but likely requires substantial settlement payments affecting near-term finances.
9 Sep
Corteva and Globachem signed a definitive agreement to form a joint venture advancing development and commercialization of new formulated crop protection solutions. Joint venture targets core crop protection innovations that could enhance Corteva product pipeline and market position.
3 Sep
Vylor launches Vylor Edge, a new investment platform for global agriculture innovation. New platform launch introduces potential moderate effects on Corteva's innovation and market positioning in agriculture.
1 Sep
Corteva launches Vylor corn trait with industry-first yield, yield stability, and advanced insect control to drive step-change gains in production and farmer profitability. Vylor launch introduces transformative seed technology that can materially expand Corteva corn market position and revenue.
28 Aug
RBC analysts identify Corteva's planned Vylor spin-off as a key catalyst for potential stock rerating. Vylor spin-off constitutes a major strategic move with potential to significantly alter Corteva's trajectory and investor sentiment.
Corteva faces near-term headwinds yet its long-term growth outlook holds steady. Near-term obstacles may pressure results while balanced long-term growth prevents major trajectory shift.
24 Aug
Corteva faces pricing pressure from Mission Produce with potential offset from higher volumes affecting revenue and margins. Pricing pressure and volume shifts can moderately influence Corteva revenue and margins in the near term.
12 Aug
Corteva raised 2026 guidance, shifting investor focus to growth drivers. Higher 2026 guidance signals materially stronger future performance prospects.
7 Aug
Corteva (CTVA) Q2 2026 earnings call transcript covers financial results, operational updates, and management outlook. Earnings call transcripts deliver core financial results and guidance that reshape investor views on performance.
31 Jul
Corteva Inc reported strong first-half performance in its Q2 2026 earnings call and raised full-year guidance. Raised guidance on strong first-half results signals materially higher revenue and earnings trajectory for Corteva.
Corteva raises 2026 outlook while split plans remain on schedule. Raised long-term outlook and advancing split represent major strategic developments likely to shift company trajectory and investor views.
Seed giant planning Johnston HQ has set date for spinoff from Corteva. Spinoff of major business unit will significantly alter Corteva's corporate structure and financials.
Corteva Q2 earnings call highlighted financial performance, segment results and forward guidance for the agricultural firm. Quarterly earnings and guidance typically produce moderate short-term share-price moves without altering long-term strategy.
Corteva Q2 earnings beat estimates while sales missed targets, and the company raised its 2026 outlook. Q2 earnings beat combined with raised 2026 outlook signals moderately positive effects on future expectations.
Corteva reported Q2 2026 results showing revenue growth from seed and crop protection segments, higher EPS, expanded margins, and raised full-year guidance driven by operational efficiencies and favorable demand. Quarterly earnings and guidance updates typically produce moderate effects on near-term stock movement and investor views without fundamentally shifting long-term trajectory.
30 Jul
Corteva delivers strong 1H 2026 results, raises FY 2026 outlook, and remains on track for October 1 separation. Strong results plus raised outlook lift financial trajectory while separation advances major restructuring.
Corteva reported Q2 earnings with emphasis on key financial metrics including revenue, earnings per share, and segment performance. Quarterly earnings results shape near-term investor sentiment and valuation for the company.
Corteva, Inc. (CTVA) reported Q2 earnings that beat estimates. Q2 earnings beat points to stronger financial results likely affecting near-term market sentiment.
29 Jul
Corteva shares rallied strongly after beating earnings expectations, leaving investors to assess if the stock is still worth buying. Earnings beat and rally reflect short-term positive results without evidence of major strategic or competitive shifts.
Corteva's seed and crop protection businesses serve as primary value drivers for investors through innovation, market share and revenue growth in agriculture. Corteva seed and crop protection segments represent core operations that shape financial performance and competitive positioning.